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Background: A strong relationship between platelet reactivity and stent thrombosis
(ST) after DES implantation was recently conﬁrmed in the prospective, multicenter
ADAPT-DES study. We herein seek to identify the angiographic predictors of 2-year
ST from this large-scale study.
Methods: Angiographic analyses were performed by an independent angiographic
core laboratory for all ST thromboses. According to a pre-speciﬁed substudy,
propensity-adjusted multivariable analysis was performed to determine angiographic
predictors of 2-year ST.
Results: Among the 8,583 patients included in the ADAPT-DES study, 92 (1.1%) pts
had ST at 2 year of follow-up. Target lesion-related ST were identiﬁed in 77 pts (82
lesions) and clinically matched with 153 pts (196 lesions) without ST. Pts with ST
were more likely to have three vessel disease, longer target lesions, more lesions
containing thrombus, moderate-to-severe calciﬁcation, ACC/AHA type C class, total
occlusions, and in saphenous vein grafts. After propensity-adjusted multivariable
analysis, ACC/AHA type C lesion (HR [95%C] ¼ 1.73 [1.05, 2.86], p¼0.03), the
presence of a total occlusion (HR [95%C] ¼ 1.39 [1.10, 1.76], p¼0.005), and PRU
>208 (HR [95%C] ¼ 1.61 [1.01, 2.57], p¼0.045) were independent predictors of ST
2 years after DES.
Conclusions: From the large-scale ADAPT-DES study, complex lesion (type C) and
total occlusions remain strong angiographic predictors of 2-year ST in the DES era.
Future studies are required to determine methods to reduce ST in the high-risk lesions,
especially in pts with high platelet reactivity on clopidogrel.
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Background: Chronic total coronary occlusion (CTO) is a frequent ﬁnding in patients
with ischemic heart disease. Our aim was to evaluate the prognostic impact of CTO on
long-term survival in patients with different severity of ischemic heart disease at the
level of one whole nation.
Methods: The study population included all consecutive patients registered in the
SCAAR registry (Swedish Coronary Angiography and Angioplasty Registry) from
2005 to 2012 who underwent angiography or PCI in Sweden. Patients with previous
coronary artery bypass graft surgery were excluded. The patients with CTO and
without CTO (no-CTO) were compared using Cox proportional-hazards regression
adjusted for the following covariates: age, indication, extent of coronary artery
disease, smoking, hypertension, hyperlipidemia, diabetes, year of intervention, prior
infarction, prior PCI, hospital and complications. Interaction test was performed
between the presence CTO and the different severity of ischemic heart disease e.g.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrone-vessel disease (1VD), two-vessel disease (2VD), three-vessel disease (3VD) and
left main (LM).
Results: The total of 91,154 patients were included in the study of which 14,609 had
a CTO. Median follow-up was 3 years. The total number of events was 9084. CTO
was an independent predictor of mortality (HR 1.29; 95%CI 1.22-1.37; P<0.001).
There was no interaction between the presence of CTO and severity of ischemic heart
disease (P¼0.32) signifying that CTO is of equal negative prognostic importance in all
subgroups. Compared to 1VD, the mortality risk was higher in 2VD (HR 1.17; 95%CI
1.11-1.24; P<0.001), 3VD (HR 1.47; 95%CI 1.38-1.58; P<0.001) and LM (HR 1.87;
95%CI 1.72-2.02; P<0.001).
Conclusions: Our study is based on the largest CTO cohort so far. The presence of
CTO confers worsening long-term survival in all subsets of coronary artery disease.
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Background: Despite recent high success rates owing to the development of new
strategies such as the retrograde approach, the procedural complications and their
management related percutaneous coronary intervention (PCI) of chronic total
occlusions (CTOs) have not been fully evaluated.
Methods: The aim of this study was to investigate in-hospital outcomes and compare
the frequency of the complications between via the retrograde approach vs. via
antegrade approach. The complications included major adverse cardiac and cerebro-
vascular events (MACCE) (deﬁned as death, myocardial infarction [MI], emergent
coronary bypass surgery, repeat PCI, or stroke), bleeding of clinical signiﬁcance, and
he procedural complications such as acute or sub-acute occlusion, distal embolization,
coronary dissection, and coronary perforation.
Results: Of 1,014 CTOs in 943 patients who underwent PCI between 2005 and 2010,
278 CTOs (27.6%) were attempted using the retrograde approach. The overall
procedural success rate was 92.4% (937/1014). The complication was the second
reason for suspended CTO procedure (7.8%; 6/77). No signiﬁcant difference was
observed in the frequency of the complications between antegrade approach and
retrograde approach except the frequency of coronary perforation that was higher in
the patients treated with retrograde approach. (Table).
Conclusions: Although the higher rate of coronary perforation in the patients treated
with retrograde approach, all cases were solved with optimal treatments in the cath-lab
and in-hospital MACCE was acceptable. Retrograde approach could be the one of the
option for the failed case wi.TCT-53
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Background: Chronic total occlusions (CTO) are complex procedures aiming to
improve the symptoms and outcomes of patients. Although a signiﬁcantly positive
ischemia/viability test is accepted by guidelines as enough to trigger a CTO attempt,
there is still controversy whether silent ischemia patients can beneﬁt as much as
symptomatic patients from this procedure.
Methods: A total of 1343 consecutive patients underwent percutaneous coronary
intervention (PCI) at our center between 2004 and 2013. We compared baseline and
procedural characteristics as well as mid-term outcome in patients with silent or
symptomatic ischemia.acts/ORAL/Miscellaneous Coronary Intervention B17
